🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of phase 1 part in this study was to determine the maximum tole...
Status
Completed
Location
Site JP81037
Start Date
2015-02-26
Trial ID
NCT02310321
Treatments Being Tested
This research is being done to assess the therapeutic efficacy and safety o...
Status
Active Not Recruiting
Location
The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology
Start Date
2022-03-01
Trial ID
NCT05177731
Treatments Being Tested
The goal of this clinical trial is to estimate the rate (probability) of co...
Status
Recruiting
Location
First Affiliated Hospital Of University of Science and Technology of China
Start Date
2024-01-01
Trial ID
NCT06221683
The purpose of this study was to determine the clinical benefit of ASP2215 ...
Status
Completed
Location
Site US10011
Start Date
2015-10-20
Trial ID
NCT02421939
This is a multicenter, randomized, open-label, pragmatic low intervention c...
Status
Recruiting
Location
University Hospital Brno
Start Date
2025-02-27
Trial ID
NCT06713837
Treatments Being Tested
This is a phase 2 study to test the hypothesis that venetoclax in combinati...
Status
Suspended
Location
Valley Children's Hospital
Start Date
2023-07-25
Trial ID
NCT05955261
This is a multicenter, randomized, controlled, open-label phase III trial e...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-04-30
Trial ID
NCT07407140
This phase II trial studies how well cladribine, idarubicin, cytarabine, an...
Status
Recruiting
Location
M D Anderson Cancer Center
Start Date
2014-05-19
Trial ID
NCT02115295
Treatments Being Tested
The safety, tolerability, and antileukemic response of ziftomenib in combin...
Status
Recruiting
Location
Banner MD Anderson Cancer Center
Start Date
2024-02-22
Trial ID
NCT06001788
Treatments Being Tested
To study the optimal therapeutic strategies for salvage treatment of refrac...
Status
Recruiting
Location
Blood Hospital
Start Date
2024-02-22
Trial ID
NCT06265545